Background: Accrual to Cancer Control and Supportive Care (CCL) studies can be challenging. Our objective was\r\nto identify facilitators and perceived barriers to successful Children�s Oncology Group (COG) CCL accrual from the\r\nclinical research associate (CRA) perspective.\r\nMethods: A survey was developed that focused on the following features from the institutional perspective:\r\n(1) Components of successful accrual; (2) Barriers to accrual; (3) Institutional changes that could enhance accrual; and\r\n(4) How COG could facilitate accrual. The survey was distributed to the lead CRA at each COG site with at least 2 CCL\r\naccruals within the previous year. The written responses were classified into themes and sub-themes.\r\nResults: 57 sites in the United States (n = 52) and Canada (n = 5) were contacted; 34 (60%) responded. The four\r\nmajor themes were: (1) Staff presence and dynamics; (2) Logistics including adequate numbers of eligible patients;\r\n(3) Interests and priorities; and (4) Resources. Suggestions for improvement began at the study design/conception\r\nstage, and included ongoing training/support and increased reimbursement or credit for successful CCL enrollment.\r\nConclusions: The comments resulted in suggestions to facilitate CCL trials in the future. Soliciting input from key\r\nteam members in the clinical trials process is important to maximizing accrual rates
Loading....